diazipine has been researched along with dihydropyridines in 14 studies
| Studies (diazipine) | Trials (diazipine) | Recent Studies (post-2010) (diazipine) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 14 | 0 | 5 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanaoka, Y; Nakayama, H; Taki, M | 1 |
| Catterall, WA; Glossmann, H; Kanaoka, Y; Nakayama, H; Striessnig, J; Taki, M | 1 |
| Kanaoka, Y; Kuniyasu, A; Nakayama, H; Taki, M | 1 |
| Kidwai, M; Misra, P; Sapra, P; Saxena, RK; Singh, M | 1 |
| Caldwell, CG; Chen, P; Donnelly, KL; Grant, SK; Hagmann, WK; Humes, JL; Kelly, TM; Maccoss, M; Pacholok, SG; Shah, SK; Shankaran, K; Wong, KK | 1 |
| Drewry, DH; Gray, DW; Hoekstra, WJ; Mehbob, A; Stewart, EL; Wiethe, RW | 1 |
| Arami, M; Gharanjig, K; Limaee, NY; Mahmoodi, NM | 1 |
| Bradner, JE; Cameron, MJ; Christie, AL; Fedorov, O; Felletar, I; Filippakopoulos, P; French, CA; Heightman, TD; Hickman, TT; Keates, T; Knapp, S; Kung, AL; La Thangue, N; McKeown, MR; Morse, EM; Munro, S; Philpott, M; Picaud, S; Qi, J; Schwartz, B; Shen, Y; Smith, WB; Wang, Y; West, N; Wiest, O | 1 |
| Chung, TW; Sun, CM; Yellol, GS | 1 |
| Hada, J; Hada, N; Higuchi, M; Kakiuchi, N; Ohtsuka, I; Sadakane, Y; Sakushima, A | 1 |
| Liu, JT; Luo, JZ; Miao, JY; Shao, JH; Shen, SL; Zhao, BX | 1 |
| Banotai, C; Baum, H; Beidler, D; Bove, S; Braden, T; Cornicelli, J; Goodman, A; Gowan, R; Hicks, J; Lightle, S; Lu, XK; Miller, H; Ogden, A; Pandit, J; Plummer, MS; Roark, H; Sadagopan, N; Sanchez, B; Sarver, R; Shahripour, A; Shen, XQ; Skalitzky, DJ; Spessard, C; Stankovic, CJ; Welch, K; Whitehead, C | 2 |
| Baas, J; Dunbar, M; Rambohul, J; Spurgeon, D; Svendsen, C; van 't Zelfde, M; Vijver, M | 1 |
14 other study(ies) available for diazipine and dihydropyridines
| Article | Year |
|---|---|
Diazipine, a novel photoaffinity probe for dihydropyridine receptors of calcium channels.
Topics: Affinity Labels; Animals; Azides; Azirines; Calcium Channel Blockers; Calcium Channels; Chromatography, Affinity; Dihydropyridines; Kinetics; Molecular Weight; Muscles; Rabbits; Receptors, Nicotinic | 1991 |
Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.
Topics: Affinity Labels; Amino Acid Sequence; Animals; Antibodies; Azirines; Calcium Channels; Cell Membrane; Dihydropyridines; Lipid Bilayers; Macromolecular Substances; Models, Structural; Molecular Sequence Data; Muscles; Peptides; Protein Conformation; Rabbits; Receptors, Nicotinic | 1991 |
Synthesis of diazipine and [3H]diazipine: novel dihydropyridines as photoaffinity probes of calcium channels.
Topics: Affinity Labels; Animals; Azirines; Calcium Channels; Dihydropyridines; In Vitro Techniques; Isotope Labeling; Myocardium; Swine | 1991 |
Microwave assisted solid support synthesis of novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazepines as potent antimicrobial agents.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Aspergillus; Azirines; Bacillus; Combinatorial Chemistry Techniques; Dihydropyridines; Gram-Negative Bacteria; Microbial Sensitivity Tests; Microwaves; Structure-Activity Relationship; Triazoles | 2001 |
Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases.
Topics: Azirines; Dihydropyridines; Enzyme Inhibitors; Humans; Nitric Oxide Synthase; Oxazepines; Thiazepines | 2004 |
Array synthesis of progesterone receptor antagonists: 3-aryl-1,2-diazepines.
Topics: Azepines; Azirines; Binding Sites; Cells, Cultured; Dihydropyridines; Humans; Ligands; Models, Chemical; Receptors, Progesterone | 2006 |
Photocatalytic degradation of agricultural N-heterocyclic organic pollutants using immobilized nanoparticles of titania.
Topics: Agrochemicals; Azirines; Catalysis; Dihydropyridines; Imidazoles; Metal Nanoparticles; Neonicotinoids; Nitro Compounds; Photochemistry; Titanium; Ultraviolet Rays; Water Pollutants, Chemical; Water Purification | 2007 |
Selective inhibition of BET bromodomains.
Topics: Amino Acid Sequence; Animals; Azirines; Binding Sites; Carcinoma, Squamous Cell; Cell Cycle Proteins; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chromatin; Dihydropyridines; Female; Humans; Mice; Mice, Nude; Models, Molecular; Molecular Sequence Data; Nuclear Proteins; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; Sequence Alignment; Skin Neoplasms; Stereoisomerism; Transcription Factors | 2010 |
Novel cyclization of bis-Boc-guanidines: expeditive traceless synthesis of 1,3,5-oxadiazinones under microwave conditions.
Topics: Amines; Azirines; Cyclization; Dihydropyridines; Guanidines; Microwaves; Polyethylene Glycols | 2010 |
The effect of structural differences in the reducing terminus of sugars on the binding affinity of carbohydrates and proteins analyzed using photoaffinity labeling.
Topics: Azirines; Carbohydrates; Dihydropyridines; Lectins; Ligands; Microscopy, Atomic Force; Photoaffinity Labels; Protein Binding | 2011 |
Novel chiral ferrocenylpyrazolo[1,5-a][1,4]diazepin-4-one derivatives--synthesis, characterization and inhibition against lung cancer cells.
Topics: Apoptosis; Azepines; Azirines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dihydropyridines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Electrochemical Techniques; Ferrous Compounds; Flow Cytometry; Humans; Hydrogen Bonding; Lung Neoplasms; Microscopy, Fluorescence; Models, Chemical; Molecular Structure; Pyrazoles; Stereoisomerism | 2013 |
Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, part I: transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors.
Topics: Animals; Azirines; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 4; Dihydropyridines; Disease Models, Animal; Drug Evaluation, Preclinical; Osteoarthritis; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Protein Binding; Structure-Activity Relationship | 2013 |
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacy.
Topics: Analgesics; Animals; Azepines; Azirines; Binding Sites; Catalytic Domain; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 2; Dihydropyridines; Disease Models, Animal; Drug Evaluation, Preclinical; Half-Life; Osteoarthritis; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Protein Binding; Pyrazoles; Rats; Structure-Activity Relationship | 2013 |
Comparison and evaluation of pesticide monitoring programs using a process-based mixture model.
Topics: Animals; Azirines; Chlorfenvinphos; Daphnia; Dihydropyridines; Environmental Monitoring; Europe; Lethal Dose 50; Limit of Detection; Models, Theoretical; Pesticide Residues; Program Evaluation | 2016 |